Compare HCM & PSNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HCM | PSNY |
|---|---|---|
| Founded | 2000 | 2017 |
| Country | Hong Kong | Sweden |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.0B |
| IPO Year | 2015 | 2021 |
| Metric | HCM | PSNY |
|---|---|---|
| Price | $13.72 | $7.86 |
| Analyst Decision | Sell | Sell |
| Analyst Count | 1 | 2 |
| Target Price | $13.75 | ★ $15.00 |
| AVG Volume (30 Days) | 77.2K | ★ 287.6K |
| Earning Date | 03-05-2026 | 04-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $20.60 | $31.06 |
| Revenue Next Year | $15.62 | $47.98 |
| P/E Ratio | $5.49 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.77 | $0.50 |
| 52 Week High | $16.99 | $23.75 |
| Indicator | HCM | PSNY |
|---|---|---|
| Relative Strength Index (RSI) | 59.84 | 27.50 |
| Support Level | $12.94 | N/A |
| Resistance Level | $15.43 | $23.01 |
| Average True Range (ATR) | 0.32 | 0.82 |
| MACD | 0.03 | -0.09 |
| Stochastic Oscillator | 75.76 | 16.35 |
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
Polestar Automotive Holding UK PLC is a pure play, premium electric car brand, designing performance cars engineered to excite consumers and drive change. It believes that it defines market standards in design, innovation and sustainability. It is determined to improve society by accelerating the shift to sustainable mobility. The company conducts its business as one operating segment with primary commercial operations in Europe, North America, Asia Pacific and various importer markets. The company generates majority of revenue from United Kingdom.